About this trial
Patients admitted to the intensive care unit frequently exhibit abnormal blood bicarbonate levels. These abnormalities are associated with patient outcomes and often prompt clinicians to modify management, either diagnostically or therapeutically (e.g., initiation or adjustment of mechanical ventilation, initiation or modification of extracorporeal renal replacement therapy, administration of specific diuretics, or sodium bicarbonate infusion).
Currently, the only way to determine blood bicarbonate concentration is through repeated blood sampling for laboratory analysis. However, this method is both discontinuous and invasive.
We have generated an in silico hypothesis suggesting that the mismatch between cellular CO₂ production/elimination and pulmonary CO₂ elimination reflects changes in blood bicarbonate levels. We propose to test this hypothesis in a cohort of intensive care unit patients.
If confirmed, indirect calorimetry could be positioned as a continuous, non-invasive monitoring tool for blood bicarbonate.
Eligibility criteria
Qualifiers
Adult patient admitted to the ICU within the past 72 hours
Receiving invasive mechanical ventilation
For whom the treating clinician plans to perform at least two blood bicarbonate measurements within the next 6 hours
No objection from the participant or their next of kin
Disqualifiers
Planned weaning from invasive mechanical ventilation or ventilator change before the second bicarbonate measurement
Inspiratory oxygen fraction > 60%
Administration of inhaled medications, including nitric oxide
Positive end-expiratory pressure (PEEP) > 15 cmH₂O
Trial design
Treatments tested in this trial
- Indirect calorimetry measurement